David Riochet
Overview
Explore the profile of David Riochet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moure A, Bekir S, Bacou E, Pruvost Q, Haurogne K, Allard M, et al.
Sci Rep
. 2022 Mar;
12(1):4681.
PMID: 35304495
A bioartificial pancreas (BAP) encapsulating high pancreatic islets concentration is a promising alternative for type 1 diabetes therapy. However, the main limitation of this approach is O supply, especially until...
2.
Bensoussan C, Champclou A, Galarraga O, Letellier G, Rahmani A, Riochet D, et al.
Gait Posture
. 2021 Feb;
85:224-231.
PMID: 33618166
Background: Several articular, muscular and neurological diseases generate mobility loss in the shoulder and pelvis girdles. Joint mobilization contributes to improving shoulder-pelvis girdles dissociation, but current mobilization techniques are not...
3.
Cabridain C, Aubert H, Kaeffer B, Badon V, Boivin M, Dochez V, et al.
BMJ Open
. 2019 Apr;
9(4):e024974.
PMID: 31005913
Introduction: Atopic dermatitis (AD) is a chronic inflammatory disease affecting 10%-15% of children in Europe. There is a need for new primary preventive therapeutic strategies in at-risk populations. Recent research...
4.
Moure A, Bacou E, Bosch S, Jegou D, Salama A, Riochet D, et al.
Biotechnol Bioeng
. 2018 Dec;
116(5):1176-1189.
PMID: 30593660
The bioartificial pancreas encapsulating pancreatic islets in immunoprotective hydrogel is a promising therapy for Type 1 diabetes. As pancreatic islets are highly metabolically active and exquisitely sensitive to hypoxia, maintaining...
5.
Salama A, Mosser M, Leveque X, Perota A, Judor J, Danna C, et al.
Diabetes
. 2017 Jan;
66(4):987-993.
PMID: 28082457
Xenocell therapy from neonate or adult pig pancreatic islets is one of the most promising alternatives to allograft in type 1 diabetes for addressing organ shortage. In humans, however, natural...
6.
Vabres B, Le Bas-Bernardet S, Riochet D, Cherel Y, Minault D, Hervouet J, et al.
Xenotransplantation
. 2014 Jul;
21(5):431-43.
PMID: 25040113
Background: Human corneal allografting is an established procedure to cure corneal blindness. However, a shortage of human donor corneas as well as compounding economic, cultural, and organizational reasons in many...
7.
Van Tricht M, Riochet D, Batard E, Martinage A, Montassier E, Potel G, et al.
Emerg Med J
. 2011 Oct;
29(10):795-7.
PMID: 21965176
Objectives: A growing number of patients die each year in hospital emergency departments (EDs). Decisions to withhold or to withdraw life-support therapies occur in 80% of patients as described in...
8.
Le Conte P, Riochet D, Labastire L, Auneau J, Legeard E, Van Tricht M, et al.
Am J Emerg Med
. 2010 Nov;
30(1):170-3.
PMID: 21035977
Objective: In France and in Belgium, as in many countries, there is a shortage of organs for transplantation, which has led to strategies to recruit older potential donors who may...
9.
Le Conte P, Riochet D, Batard E, Volteau C, Giraudeau B, Arnaudet I, et al.
Intensive Care Med
. 2010 Mar;
36(5):765-72.
PMID: 20229044
Purpose: To describe the characteristics of patients who die in emergency departments and the decisions to withhold or withdraw life support. Methods: We undertook a 4-month prospective survey in 174...